{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:30:47Z","timestamp":1740123047723,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","award":["POCI-01-0145-FEDER-028893"],"award-info":[{"award-number":["POCI-01-0145-FEDER-028893"]}]},{"name":"ESIF - European Structural and Investment Funds","award":["POCI-01-0145-FEDER-042779"],"award-info":[{"award-number":["POCI-01-0145-FEDER-042779"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11046-023-00734-0","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T06:02:30Z","timestamp":1682488950000},"page":"231-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combined Application of Antisense Oligomers to Control Transcription Factors of Candida albicans Biofilm Formation"],"prefix":"10.1007","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9830-0367","authenticated-orcid":false,"given":"D.","family":"Ara\u00fajo","sequence":"first","affiliation":[]},{"given":"B.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"D.","family":"Vilas Boas","sequence":"additional","affiliation":[]},{"given":"M. E.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"M.","family":"Henriques","sequence":"additional","affiliation":[]},{"given":"S.","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"issue":"10","key":"734_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/J.CMI.2019.04.024","volume":"25","author":"P Koehler","year":"2019","unstructured":"Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25(10):1200\u201312. https:\/\/doi.org\/10.1016\/J.CMI.2019.04.024.","journal-title":"Clin Microbiol Infect"},{"key":"734_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tim.2016.09.004","volume":"1","author":"D Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo D, Henriques M, Silva S. Portrait of Candida species biofilm regulatory network genes. Trends Microbiol. 2017;1:62\u201375. https:\/\/doi.org\/10.1016\/j.tim.2016.09.004.","journal-title":"Trends Microbiol"},{"issue":"3","key":"734_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11046-020-00445-w","volume":"185","author":"PP Barros","year":"2020","unstructured":"Barros PP, Rossoni RD, Souza CM, Scorzoni L, Fenley JC, Junqueira JC. Candida biofilms: an update on developmental mechanisms and therapeutic challenges. Mycopathologia. 2020;185(3):415\u201324. https:\/\/doi.org\/10.1007\/s11046-020-00445-w.","journal-title":"Mycopathologia"},{"key":"734_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/J.1365-2958.2003.03300.X","volume":"47","author":"K Sohn","year":"2003","unstructured":"Sohn K, Urban C, Brunner H, Rupp S. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol Microbiol. 2003;47:89\u2013102. https:\/\/doi.org\/10.1046\/J.1365-2958.2003.03300.X.","journal-title":"Mol Microbiol"},{"key":"734_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/J.1574-6968.2006.00109.X","volume":"256","author":"SP Saville","year":"2006","unstructured":"Saville SP, Thomas DP, L\u00f3pez Ribot JL. A role for Efg1p in Candida albicans interactions with extracellular matrices. FEMS Microbiol Lett. 2006;256:151\u20138. https:\/\/doi.org\/10.1111\/J.1574-6968.2006.00109.X.","journal-title":"FEMS Microbiol Lett"},{"key":"734_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","volume":"148","author":"CJ Nobile","year":"2012","unstructured":"Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2012;148:126\u201338. https:\/\/doi.org\/10.1016\/j.cell.2011.10.048.","journal-title":"Cell"},{"key":"734_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2018_144","volume":"422","author":"V Basso","year":"2018","unstructured":"Basso V, D\u2019Enfert C, Znaidi S, Bachellier-Bassi S. From genes to networks: The regulatory circuitry controlling Candida albicans morphogenesis. Curr Top Microbiol Immunol. 2018;422:1\u201339. https:\/\/doi.org\/10.1007\/82_2018_144.","journal-title":"Curr Top Microbiol Immunol"},{"key":"734_CR8","doi-asserted-by":"publisher","first-page":"1003305","DOI":"10.1371\/journal.ppat.1003305","volume":"9","author":"CH Lin","year":"2013","unstructured":"Lin CH, Kabrawala S, Fox EP, Nobile CJ, Johnson AD. Genetic control of conventional and pheromone-stimulated biofilm formation in Candida albicans. PLoS Pathog. 2013;9:1003305. https:\/\/doi.org\/10.1371\/journal.ppat.1003305.","journal-title":"PLoS Pathog"},{"key":"734_CR9","doi-asserted-by":"publisher","first-page":"e1000783","DOI":"10.1371\/journal.pgen.1000783","volume":"5","author":"OR Homann","year":"2009","unstructured":"Homann OR, Dea J, Noble SM, Johnson AD. A phenotypic profile of the Candida albicans regulatory network. PLoS Genet. 2009;5:e1000783. https:\/\/doi.org\/10.1371\/journal.pgen.1000783.","journal-title":"PLoS Genet"},{"issue":"5\u20136","key":"734_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1440-1681.2006.04403.x","volume":"33","author":"JHP Chan","year":"2006","unstructured":"Chan JHP, Lim S, Wong WSF. Antisense Oligonucleotides: from design to therapeutic application. Clin Exp Pharmacol Physiol. 2006;33(5\u20136):533\u201340.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"734_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S2215-0366(16)30284-X.Epidemiology","volume":"3","author":"EK Sully","year":"2016","unstructured":"Sully EK, Geller BL. Antisense antimicrobial therapeutics. Curr Opin Microbiol. 2016;3:47\u201355. https:\/\/doi.org\/10.1016\/S2215-0366(16)30284-X.Epidemiology.","journal-title":"Curr Opin Microbiol"},{"key":"734_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1073\/pnas.0337462100","volume":"100","author":"MD Disney","year":"2003","unstructured":"Disney MD, Haidaris CG, Turner DH. Uptake and antifungal activity of oligonucleotides in Candida albicans. Proc Natl Acad Sci U S A. 2003;100:1530\u20134. https:\/\/doi.org\/10.1073\/pnas.0337462100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"734_CR13","first-page":"347","volume":"1","author":"N Dias","year":"2002","unstructured":"Dias N, Stein CA. Antisense oligonucleotides: Basic concepts and mechanisms. Mol Cancer Ther. 2002;1:347\u201355.","journal-title":"Mol Cancer Ther"},{"key":"734_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","volume":"50","author":"CF Bennett","year":"2010","unstructured":"Bennett CF, Swayze EE. RNA targeting therapeutics: Molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol. 2010;50:259\u201393. https:\/\/doi.org\/10.1146\/annurev.pharmtox.010909.105654.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"734_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.omtn.2019.09.016","volume":"18","author":"D Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo D, Azevedo NM, Barbosa A, Almeida C, Rodrigues ME, Henriques M, et al. Application of 2\u2032-OMethylRNA\u2032 antisense oligomer to control Candida albicans EFG1 virulence determinant. Mol Ther Nucleic Acids. 2019;18:508\u201317. https:\/\/doi.org\/10.1016\/j.omtn.2019.09.016.","journal-title":"Mol Ther Nucleic Acids"},{"key":"734_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.omtn.2021.12.018","volume":"27","author":"D Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo D, Mil-Homens D, Henriques M, Silva S. Anti-EFG1 2\u2032-OMethylRNA oligomer inhibits Candida albicans filamentation and attenuates the candidiasis in Galleria mellonella. Mol Ther Nucleic Acids. 2022;27:517\u201323. https:\/\/doi.org\/10.1016\/j.omtn.2021.12.018.","journal-title":"Mol Ther Nucleic Acids"},{"key":"734_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s13311-013-0194-5","volume":"10","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Miller TM. Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics. 2013;10:486\u201397. https:\/\/doi.org\/10.1007\/s13311-013-0194-5.","journal-title":"Neurotherapeutics"},{"key":"734_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt.3765","volume":"35","author":"A Khvorova","year":"2017","unstructured":"Khvorova A, Watts JK. The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol. 2017;35:238\u201348. https:\/\/doi.org\/10.1038\/nbt.3765.","journal-title":"Nat Biotechnol"},{"key":"734_CR19","doi-asserted-by":"publisher","first-page":"8955","DOI":"10.1093\/nar\/gkv920","volume":"43","author":"TA Vickers","year":"2015","unstructured":"Vickers TA, Crooke ST. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA. Nucleic Acids Res. 2015;43:8955\u201363. https:\/\/doi.org\/10.1093\/nar\/gkv920.","journal-title":"Nucleic Acids Res"},{"key":"734_CR20","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1128\/jcm.33.9.2476-2479.1995","volume":"33","author":"DW Williams","year":"1995","unstructured":"Williams DW, Wilson MJ, Lewis MAO, Potts AJC. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol. 1995;33:2476\u20139. https:\/\/doi.org\/10.1128\/jcm.33.9.2476-2479.1995.","journal-title":"J Clin Microbiol"},{"key":"734_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3109\/13693780802549594","volume":"47","author":"S Silva","year":"2009","unstructured":"Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009;47:681\u20139. https:\/\/doi.org\/10.3109\/13693780802549594.","journal-title":"Med Mycol"},{"key":"734_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2199-7-25","volume":"7","author":"H Nailis","year":"2006","unstructured":"Nailis H, Coenye T, Van Nieuwerburgh F, Deforce D, Nelis HJ. Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol. 2006;7:1\u20139. https:\/\/doi.org\/10.1186\/1471-2199-7-25.","journal-title":"BMC Mol Biol"},{"key":"734_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00284-010-9649-7","volume":"61","author":"S Silva","year":"2010","unstructured":"Silva S, Henriques M, Oliveira R, Williams D, Azeredo J. In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol. 2010;61:534\u201340. https:\/\/doi.org\/10.1007\/s00284-010-9649-7.","journal-title":"Curr Microbiol"},{"key":"734_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1021\/AC60111A017\/ASSET\/AC60111A017.FP.PNG_V03","volume":"28","author":"M Dubois","year":"1956","unstructured":"Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 1956;28:350\u20136. https:\/\/doi.org\/10.1021\/AC60111A017\/ASSET\/AC60111A017.FP.PNG_V03.","journal-title":"Anal Chem"},{"unstructured":"International Organization for Standardization. ISO10993\u20135:2009. Biological evaluation of medical devices. Part 5: Tests for in vitro cytotoxicity. 3rd edn edition, 2009.","key":"734_CR25"},{"key":"734_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1517\/14728222.2015.1056155","volume":"19","author":"SP Kenney","year":"2015","unstructured":"Kenney SP, Meng XJ. Therapeutic targets for the treatment of hepatitis e virus infection. Expert Opin Ther Targets. 2015;19:1245\u201360. https:\/\/doi.org\/10.1517\/14728222.2015.1056155.","journal-title":"Expert Opin Ther Targets"},{"key":"734_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mib.2016.05.017","volume":"33","author":"EK Sully","year":"2016","unstructured":"Sully EK, Geller BL. Antisense antimicrobial therapeutics. Curr Opin Microbiol. 2016;33:47\u201355. https:\/\/doi.org\/10.1016\/j.mib.2016.05.017.","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"734_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/biom10020316","volume":"10","author":"A Batista-duharte","year":"2020","unstructured":"Batista-duharte A, Sendra L, Jos M, Damiana T, Carlos IZ, Ali\u00f1o SF. Progress in the use of antisense oligonucleotides for vaccine improvement. Biomolecules. 2020;10(2):316. https:\/\/doi.org\/10.3390\/biom10020316.","journal-title":"Biomolecules"},{"key":"734_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","volume":"148","author":"CJ Nobile","year":"2011","unstructured":"Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2011;148:126\u201338. https:\/\/doi.org\/10.1016\/j.cell.2011.10.048.","journal-title":"Cell"},{"key":"734_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1172\/JCI200113885.Antisense","volume":"108","author":"CA Stein","year":"2001","unstructured":"Stein CA. The experimental use of antisense oligonucleotides: a guide for the perplexed. J Clin Invest. 2001;108:641\u20134. https:\/\/doi.org\/10.1172\/JCI200113885.Antisense.","journal-title":"J Clin Invest"},{"key":"734_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1099\/jmm.0.46569-0","volume":"55","author":"MA Al-Fattani","year":"2006","unstructured":"Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol. 2006;55:999\u20131008. https:\/\/doi.org\/10.1099\/jmm.0.46569-0.","journal-title":"J Med Microbiol"},{"key":"734_CR32","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","volume":"36","author":"S Silva","year":"2012","unstructured":"Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev. 2012;36:288\u2013305. https:\/\/doi.org\/10.1111\/j.1574-6976.2011.00278.x.","journal-title":"FEMS Microbiol Rev"},{"key":"734_CR33","doi-asserted-by":"publisher","first-page":"e00451","DOI":"10.1128\/mBio.00451-18","volume":"9","author":"E Dominguez","year":"2018","unstructured":"Dominguez E, Zarnowski R, Sanchez H, Covelli AS, Westler WM, Azadi P, et al. Conservation and divergence in the Candida species biofilm matrix mannan-glucan complex structure, function, and genetic control. MBio. 2018;9:e00451-e518. https:\/\/doi.org\/10.1128\/mBio.00451-18.","journal-title":"MBio"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00734-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-023-00734-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00734-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T16:22:37Z","timestamp":1687969357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-023-00734-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1007\/s11046-023-00734-0","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"type":"print","value":"0301-486X"},{"type":"electronic","value":"1573-0832"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}